{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:20:19Z","timestamp":1791069619103,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T00:00:00Z","timestamp":1247702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s12012-009-9046-2","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T12:22:14Z","timestamp":1247660534000},"page":"134-141","source":"Crossref","is-referenced-by-count":29,"title":["Dose Dependency and Reversibility of Serotonin-Induced Valvular Heart Disease in Rats"],"prefix":"10.1007","volume":"9","author":[{"given":"Steven","family":"Droogmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Roosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cosyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Degaillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hernot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Weytjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Garbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Caveliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Pipeleers-Marichal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe R.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Schoors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Lahoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Van Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,16]]},"reference":[{"key":"9046_CR1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","volume":"337","author":"HM Connolly","year":"1997","unstructured":"Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., et al. (1997). Valvular heart disease associated with fenfluramine-phentermine. New England Journal of Medicine, 337, 581\u2013588.","journal-title":"New England Journal of Medicine"},{"key":"9046_CR2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(04)15945-X","volume":"363","author":"G Camp Van","year":"2004","unstructured":"Van Camp, G., Flamez, A., Cosyns, B., Weytjens, C., Muyldermans, L., Van Zandijcke, M., et al. (2004). Treatment of Parkinson\u2019s disease with pergolide and relation to restrictive valvular heart disease. Lancet, 363, 1179\u20131183.","journal-title":"Lancet"},{"key":"9046_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","volume":"356","author":"R Schade","year":"2007","unstructured":"Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007). Dopamine agonists and the risk of cardiac-valve regurgitation. New England Journal of Medicine, 356, 29\u201338.","journal-title":"New England Journal of Medicine"},{"key":"9046_CR4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","volume":"356","author":"R Zanettini","year":"2007","unstructured":"Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007). Valvular heart disease and the use of dopamine agonists for Parkinson\u2019s disease. New England Journal of Medicine, 356, 39\u201346.","journal-title":"New England Journal of Medicine"},{"key":"9046_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-9149(00)00840-7","volume":"86","author":"NE Lepor","year":"2000","unstructured":"Lepor, N. E., Gross, S. B., Daley, W. L., Samuels, B. A., Rizzo, M. J., Luko, S. P., et al. (2000). Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease. American Journal of Cardiology, 86, 107.","journal-title":"American Journal of Cardiology"},{"key":"9046_CR6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.ijo.0801020","volume":"23","author":"R Li","year":"1999","unstructured":"Li, R., Serdula, M. K., Williamson, D. F., Bowman, B. A., Graham, D. J., & Green, L. (1999). Dose-effect of fenfluramine use on the severity of valvular heart disease among fen\u2013phen patients with valvulopathy. International Journal of Obesity, 23, 926\u2013928.","journal-title":"International Journal of Obesity"},{"key":"9046_CR7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archneur.64.12.1721","volume":"64","author":"JC Corvol","year":"2007","unstructured":"Corvol, J. C., Anzouan-Kacou, J. B., Fauveau, E., Bonnet, A. M., Lebrun-Vignes, B., Girault, C., et al. (2007). Heart valve regurgitation, pergolide use, and parkinson disease: An observational study and meta-analysis. Archives of Neurology, 64, 1721\u20131726.","journal-title":"Archives of Neurology"},{"key":"9046_CR8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/mds.22036","volume":"23","author":"K Yamashiro","year":"2008","unstructured":"Yamashiro, K., Komine-Kobayashi, M., Hatano, T., Urabe, T., Mochizuki, H., Hattori, N., et al. (2008). The frequency of cardiac valvular regurgitation in Parkinson\u2019s disease. Movement Disorders, 23, 935\u2013941.","journal-title":"Movement Disorders"},{"key":"9046_CR9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1741-7015-6-34","volume":"6","author":"CF Dahl","year":"2008","unstructured":"Dahl, C. F., Allen, M. R., Urie, P. M., & Hopkins, P. N. (2008). Valvular regurgitation and surgery associated with fenfluramine use: An analysis of 5743 individuals. BMC Medicine, 6, 34.","journal-title":"BMC Medicine"},{"key":"9046_CR10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1331.2006.01221.x","volume":"13","author":"E Ruzicka","year":"2006","unstructured":"Ruzicka, E., Linkova, H., Penicka, M., Roth, J., Ulmanova, O., Novakova, L., et al. (2006). Valvular heart disease is rare in Parkinson\u2019s disease patients treated with pergolide. European Journal of Neurology, 13, 82.","journal-title":"European Journal of Neurology"},{"key":"9046_CR11","first-page":"221","volume":"46","author":"M Muraki","year":"2005","unstructured":"Muraki, M., Mikami, T., Kitaguchi, M., Sugawara, T., Isonishi, K., Kaneko, S., et al. (2005). Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson\u2019s disease. Journal of Cardiology, 46, 221\u2013227.","journal-title":"Journal of Cardiology"},{"key":"9046_CR12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-134-4-200102200-00008","volume":"134","author":"ST Mast","year":"2001","unstructured":"Mast, S. T., Jollis, J. G., Ryan, T., Anstrom, K. J., & Crary, J. L. (2001). The progression of fenfluramine-associated valvular heart disease assessed by echocardiography. Annals of Internal Medicine, 134, 261\u2013266.","journal-title":"Annals of Internal Medicine"},{"key":"9046_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-134-4-200102200-00009","volume":"134","author":"NJ Weissman","year":"2001","unstructured":"Weissman, N. J., Panza, J. A., Tighe, J. F., & Gwynne, J. T. (2001). Natural history of valvular regurgitation 1\u00a0year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 134, 267\u2013273.","journal-title":"Annals of Internal Medicine"},{"key":"9046_CR14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00415-008-0839-1","volume":"255","author":"D Dupuy","year":"2008","unstructured":"Dupuy, D., Lesbre, J. P., Gerard, P., Andrejak, M., & Godefroy, O. (2008). Valvular heart disease in patients with Parkinson\u2019s disease treated with pergolide. Course following treatment modifications. Journal of Neurology, 255, 1045\u20131048.","journal-title":"Journal of Neurology"},{"key":"9046_CR15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ejechocard\/jen202","volume":"9","author":"S Droogmans","year":"2008","unstructured":"Droogmans, S., Cosyns, B., & Van Camp, G. (2008). Pergolide and valvular heart disease: the lower the better? European Journal of Echocardiography, 9, 717\u2013718.","journal-title":"European Journal of Echocardiography"},{"key":"9046_CR16","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/eurheartj\/ehm263","volume":"28","author":"S Droogmans","year":"2007","unstructured":"Droogmans, S., Franken, P. R., Garbar, C., Weytjens, C., Cosyns, B., Lahoutte, T., et al. (2007). In vivo model of drug-induced valvular heart disease in rats: Pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology. European Heart Journal, 28, 2156\u20132162.","journal-title":"European Heart Journal"},{"key":"9046_CR17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","volume":"111","author":"BI Gustafsson","year":"2005","unstructured":"Gustafsson, B. I., Tommeras, K., Nordrum, I., Loennechen, J. P., Brunsvik, A., Solligard, E., et al. (2005). Long-term serotonin administration induces heart valve disease in rats. Circulation, 111, 1517\u20131522.","journal-title":"Circulation"},{"key":"9046_CR18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","volume":"356","author":"BL Roth","year":"2007","unstructured":"Roth, B. L. (2007). Drugs and valvular heart disease. New England Journal of Medicine, 356, 6\u20139.","journal-title":"New England Journal of Medicine"},{"key":"9046_CR19","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","volume":"102","author":"RB Rothman","year":"2000","unstructured":"Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., et al. (2000). Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation, 102, 2836\u20132841.","journal-title":"Circulation"},{"key":"9046_CR20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euje.2006.03.009","volume":"7","author":"C Weytjens","year":"2006","unstructured":"Weytjens, C., Cosyns, B., D\u2019Hooge, J., Gallez, C., Droogmans, S., Lahoute, T., et al. (2006). Doppler myocardial imaging in adult male rats: Reference values and reproducibility of velocity and deformation parameters. European Journal of Echocardiography, 7, 411\u2013417.","journal-title":"European Journal of Echocardiography"},{"key":"9046_CR21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00395-003-0401-3","volume":"98","author":"T Reffelmann","year":"2003","unstructured":"Reffelmann, T., & Kloner, R. A. (2003). Transthoracic echocardiography in rats. Evaluation of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging. Basic Research in Cardiology, 98, 275\u2013284.","journal-title":"Basic Research in Cardiology"},{"key":"9046_CR22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00395-006-0627-y","volume":"102","author":"AB Stein","year":"2007","unstructured":"Stein, A. B., Tiwari, S., Thomas, P., Hunt, G., Levent, C., Stoddard, M. F., et al. (2007). Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Research in Cardiology, 102, 28\u201341.","journal-title":"Basic Research in Cardiology"},{"key":"9046_CR23","first-page":"H1967","volume":"277","author":"XP Yang","year":"1999","unstructured":"Yang, X. P., Liu, Y. H., Rhaleb, N. E., Kurihara, N., Kim, H. E., & Carretero, O. A. (1999). Echocardiographic assessment of cardiac function in conscious and anesthetized mice. American Journal of Physiology, 277, H1967\u2013H1974.","journal-title":"American Journal of Physiology"},{"key":"9046_CR24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ultrasmedbio.2008.10.006","volume":"35","author":"S Droogmans","year":"2009","unstructured":"Droogmans, S., Roosens, B., Cosyns, B., Hernot, S., Weytjens, C., Degaillier, C., et al. (2009). Echocardiographic and histological assessment of age-related valvular changes in normal rats. Ultrasound in Medicine & Biology, 35, 558\u2013565.","journal-title":"Ultrasound in Medicine & Biology"},{"key":"9046_CR25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijcard.2008.02.019","volume":"129","author":"BI Gustafsson","year":"2008","unstructured":"Gustafsson, B. I., Hauso, O., Drozdov, I., Kidd, M., & Modlin, I. M. (2008). Carcinoid heart disease. International Journal of Cardiology, 129, 318\u2013324.","journal-title":"International Journal of Cardiology"},{"key":"9046_CR26","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/01.CIR.101.17.2071","volume":"101","author":"JG Jollis","year":"2000","unstructured":"Jollis, J. G., Landolfo, C. K., Kisslo, J., Constantine, G. D., Davis, K. D., & Ryan, T. (2000). Fenfluramine and phentermine and cardiovascular findings: Effect of treatment duration on prevalence of valve abnormalities. Circulation, 101, 2071\u20132077.","journal-title":"Circulation"},{"key":"9046_CR27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/01.wnl.0000238508.68593.1d","volume":"67","author":"M Yamamoto","year":"2006","unstructured":"Yamamoto, M., Uesugi, T., & Nakayama, T. (2006). Dopamine agonists and cardiac valvulopathy in Parkinson disease\u2014a case-control study. Neurology, 67, 1225\u20131229.","journal-title":"Neurology"},{"key":"9046_CR28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1067\/mhj.2002.126733","volume":"144","author":"M Sachdev","year":"2002","unstructured":"Sachdev, M., Miller, W. C., Ryan, T., & Jollis, J. G. (2002). Effect of fenfluramine-derivative diet pills on cardiac valves: A meta-analysis of observational studies. American Heart Journal, 144, 1065\u20131073.","journal-title":"American Heart Journal"},{"key":"9046_CR29","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1001\/jama.286.16.2011","volume":"286","author":"JM Gardin","year":"2001","unstructured":"Gardin, J. M., Weissman, N. J., Leung, C., Panza, J. A., Fernicola, D., Davis, K. D., et al. (2001). Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine\/fenfluramine. JAMA, 286, 2011\u20132014.","journal-title":"JAMA"},{"key":"9046_CR30","first-page":"827","volume":"10","author":"NM Rajamannan","year":"2001","unstructured":"Rajamannan, N. M., Caplice, N., Anthikad, F., Sebo, T. J., Orszulak, T. A., Edwards, W. D., et al. (2001). Cell proliferation in carcinoid valve disease: A mechanism for serotonin effects. Journal of Heart Valve Disease, 10, 827\u2013831.","journal-title":"Journal of Heart Valve Disease"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-009-9046-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-009-9046-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-009-9046-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:40:19Z","timestamp":1559425219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-009-9046-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,16]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["9046"],"URL":"https:\/\/doi.org\/10.1007\/s12012-009-9046-2","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,16]]}}}